- Submit accurate diagnosis codes (ICD-10) supporting the medical necessity of the drug, corresponding to the patient's condition, such as autoimmune disorders treated by infliximab-axxq
With antibiotic resistance on the rise and chronic infections difficult to treat, researchers are studying what our bodies are already armed with, and LL-37 is proving to be much more intriguing than we ever realized
Cham: Springer International Publishing, 2018, pp.269291
Advanced models, such as patient-derived organoids or heterotypic spheroids incorporating cancer-associated fibroblasts and immune cells, are urgently needed to bridge this translational gap
READ the full study in RAPM: #PhantomLimbPain #Cryoneurolysis #PainMedicine #RegionalAnesthesia #ClinicalResearch #Innovation To view or add a comment, sign in Ophthopedia Update:Mitomycin C in Non-Endoscopic Endonasal Dacryocystorhinostomy: A Randomized Clinical Trial involving 442 cases: Mitomycin C (MMC) is used as an adjuvant in endonasal endoscopic dacryocystorhinostomy (EN-DCR) despite the existing heterogeneity in the literature on the concentration, duration of application, indication and outcomes
A recent study found that one out of every five people who recovered from COVID-19 reported experiencing what's known as Long COVID
